The new standard in GCP training is available now — and it’s free for ACRP Members.
Learn More
The U.S. Food and Drug Administration (FDA) affirmed its commitment to leveraging new technologies and promoting aspects of decentralized clinical trials (DCTs) in its Prescription Drug User Fee Act (PDUFA VII) commitment letter released on August 23. Among other promises, FDA said it will follow a Data and Technology Modernization Strategy for current and […]
Many people applying for entry-level clinical research jobs may begin their journey by enrolling in a certificate program. They invest months or years, not to mention thousands of dollars, toward earning a certificate, yet upon finishing and hitting the job markets, are likely to still be dealing with unresponsive hiring managers who are looking for […]
PAID MESSAGE Lauren Miceli, Digital Marketing Specialist, Bio-Optronics, Inc. In the world of clinical trials, researchers and patients often approach studies from different perspectives. Researchers want a successful go-to-market product or publishable finding; patients want to know how the study will help their health, and how much they will get paid. This disconnect can be problematic […]
Although a big step has been taken now that the U.S. Food and Drug Administration (FDA) has approved a cannabis-based drug for the first time, one researcher with experience in cannabis studies says how cannabidiol (CBD), the main ingredient behind the effects of such drugs, is classified in the U.S. and Canada will continue to […]
The Singapore Ministry of Health recently set aside $35m to help train and develop CRCs in the region. The investment will fund CRC salaries and national training and certification programs via the new SCRI Academy. Following ACRP’s announcement of a new partnership with Singapore Clinical Research Institute to raise CRC professionalism in Singapore, ACRP […]
